SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950152-07-000143
Filing Date
2007-01-10
Accepted
2007-01-09 18:07:20
Documents
4
Period of Report
2007-01-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 MYLAN LABORATORIES 8-K l23992ae8vk.htm 8-K 28412
2 EX-10.1 l23992aexv10w1.htm EX-10.1 44144
3 EX-10.2 l23992aexv10w2.htm EX-10.2 90091
4 EX-99.1 l23992aexv99w1.htm EX-99.1 9056
  Complete submission text file 0000950152-07-000143.txt   173528
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Filer) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-09114 | Film No.: 07521414
SIC: 2834 Pharmaceutical Preparations